Aclaris Therapeutics, Inc. Skyrocketed

Mon, Nov 18, 2024 at 07:36 PM
Aclaris Therapeutics, Inc. Skyrocketed

Aclaris Therapeutics, Inc. (ACRS:NASDAQ) jumped higher at $3.14, a gain of 53.2%. On Mon, Nov 18, 2024, ACRS:NASDAQ hit a New 2-Week High of $3.14. The stock appeared on our News Catalysts scanner on Mon, Nov 18, 2024 at 09:47 AM in the 'AGREEMENT' category. From Mon, Nov 04, 2024, the stock recorded 50.00% Up Days and 63.64% Green Days

About Aclaris Therapeutics, Inc. (ACRS:NASDAQ)

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.